261201800035C (N01) | |||
---|---|---|---|
Title | Topic 374 - Phase I - Targeted and Sustained Release Microparticles for Colon Cancer Chemoprevention | ||
Institution | ZYMERON CORPORATION, , | ||
Principal Investigator | -, - | NCI Program Director | N/A |
Cancer Activity | N/A | Division | N/A |
Funded Amount | $299,810 | Project Dates | null - null |
Fiscal Year | 2018 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) Bioengineering (50.0%) Chemoprevention (100.0%) Digestive Diseases (100.0%) |
Colon/Rectum (100.0%) | ||
Research Type | |||
Resources and Infrastructure Related to Prevention Resources and Infrastructure Related to Treatment and the Prevention of Recurrence |
|||
Abstract | |||
No abstract available. |